[Coenzyme q10 in complex therapy of patients with ischemic heart disease].

The paper contains results of assessment of clinical efficacy and safety of coenzyme Q10 in patients with ischemic heart disease. Coenzyme Q10 (60 mg/day for 8 weeks) added to basic treatment of patients with stable class II-III angina significantly improved clinical status of these patients without clinically significant side effects.

RCT Entities:   Population Interventions Outcomes